TPRA1 and neoplasm: Previous studies demonstrate that viral receptor MXRA8 promotes OVM replication and tumor killing, but MXRA8 alone is not sufficient to predict therapeutic outcomes.[23] Here, we show that TPRA1 expression robustly correlates with OVM efficacy across in vitro, in vivo, and ex vivo models, serving as an independent biomarker of therapeutic response.